Joseph Caprini/LinkedIn
Nov 15, 2025, 08:19
Joseph Caprini Released His UIP 2025 Session on VTE Recurrence Risk
Joseph Caprini, Senior Clinician Educator at The University of Chicago Pritzker School of Medicine, shared on LinkedIn:
”Just released my UIP 2025 session with Alfonso J. Tafur MD MS MBA RPVI on measuring VTE recurrence risk and tailoring treatment.
Dr. Caprini discusses how to pinpoint patients at greatest risk of VTE recurrence and highlights the value of the Caprini Risk Score in guiding long-term prevention.
He also explains how biomarkers, imaging, clinical history, and practical decision frameworks support more precise assessments and determine when extended prophylaxis is warranted.
Stay updated with Hemostasis Today.
-
Jul 13, 2026, 17:21Stefano Navarro: Presenting Our Recently Published Article at ISTH 2026
-
Jul 13, 2026, 17:12Santagata Davide: A Great Session and an Incredible Opportunity to Present Our Research at ISTH 2026
-
Jul 13, 2026, 16:26Real-World Data Across Time Reveal Important Advances in Hemophilia Treatment – ATHN
-
Jul 13, 2026, 16:19Mary Cushman: Celebrating Our Incredible ISTH Council Members in Paris
-
Jul 13, 2026, 16:17Wolfgang Miesbach: Gene Therapy Shows Promising Early Results in Adolescents With Hemophilia B at ISTH 2026
-
Jul 13, 2026, 16:06Dino Mehic: Honored to Receive the ISTH Early Career Top Reviewer Awards
-
Jul 13, 2026, 16:01Advancing DIC Diagnosis in Cirrhosis Through Disease-Specific Risk Stratification – JTH
-
Jul 13, 2026, 15:52Joshua Muia: Presenting Our Research on ADAMTS13/VWF Dysregulation in Sepsis at ISTH 2026
-
Jul 13, 2026, 15:42Marc Carrier: Important New Data From the API-CAT Trial on Recurrent VTE During Extended Apixaban Therapy